Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites

Details for Australian Patent Application No. 2005215790 (hide)

Owner Sepracor Inc.

Inventors Barberich, Timothy

Agent Pizzeys

Pub. Number AU-A-2005215790

PCT Pub. Number WO2005/079787

Priority 60/545,710 17.02.04 US

Filing date 17 February 2005

Wipo publication date 1 September 2005

International Classifications

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/079787 Priority application(s): WO2005/079787

15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005215805-Batteries and methods of manufacture and use

2005215788-Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-he xahydropyrrolo(2,3-b)indol-5-yl phenylcarbamate